Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001829126-25-006736
Filing Date
2025-08-26
Accepted
2025-08-26 16:11:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D  
1 primary_doc.xml SCHEDULE 13D 24006
  Complete submission text file 0001829126-25-006736.txt   25485
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Subject) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D | Act: 34 | File No.: 005-83670 | Film No.: 251257713
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 44, TOWER 100, THE TOWERS WINSTON CHURCHILL, PAITILLA PANAMA CITY R1 07196
Business Address
Lazar David E. (Filed by) CIK: 0001932843 (see all company filings)

Type: SCHEDULE 13D